AU5781800A - Methods and compositions for assaying analytes - Google Patents

Methods and compositions for assaying analytes

Info

Publication number
AU5781800A
AU5781800A AU57818/00A AU5781800A AU5781800A AU 5781800 A AU5781800 A AU 5781800A AU 57818/00 A AU57818/00 A AU 57818/00A AU 5781800 A AU5781800 A AU 5781800A AU 5781800 A AU5781800 A AU 5781800A
Authority
AU
Australia
Prior art keywords
compositions
methods
assaying analytes
analytes
assaying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57818/00A
Inventor
Chong-Sheng Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Atomics Corp
Original Assignee
General Atomics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/347,878 external-priority patent/US6376210B1/en
Application filed by General Atomics Corp filed Critical General Atomics Corp
Publication of AU5781800A publication Critical patent/AU5781800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
AU57818/00A 1999-07-06 2000-06-30 Methods and compositions for assaying analytes Abandoned AU5781800A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09347878 1999-07-06
US09/347,878 US6376210B1 (en) 1999-07-06 1999-07-06 Methods and compositions for assaying analytes
US45720599A 1999-12-06 1999-12-06
US09457205 1999-12-06
PCT/US2000/018057 WO2001002600A2 (en) 1999-07-06 2000-06-30 Detection of analytes using attenuated enzymes

Publications (1)

Publication Number Publication Date
AU5781800A true AU5781800A (en) 2001-01-22

Family

ID=26995460

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57818/00A Abandoned AU5781800A (en) 1999-07-06 2000-06-30 Methods and compositions for assaying analytes

Country Status (4)

Country Link
AU (1) AU5781800A (en)
CA (1) CA2377665A1 (en)
GB (1) GB2368641B (en)
WO (1) WO2001002600A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192729B2 (en) 1999-07-06 2007-03-20 General Atomics Methods for assaying homocysteine
US7919098B2 (en) 2002-03-26 2011-04-05 Zensun ( Shanghai ) Sci & Tech Co., Ltd. ErbB-3 based methods and compositions for treating neoplasms
AU2003251550A1 (en) 2002-06-17 2003-12-31 The Regents Of The University Of Colorado HUMAN CYSTATHIONINE Beta-SYNTHASE VARIANTS AND METHODS OF PRODU CTION THEREOF
US7098189B2 (en) 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
JP2006512080A (en) * 2002-12-31 2006-04-13 ロディ ファーマ，インコーポレイティド Bindingzyme array and high-throughput proteomics method
US8476034B2 (en) 2003-07-10 2013-07-02 General Atomics Methods and compositions for assaying homocysteine
US7097968B2 (en) 2003-07-10 2006-08-29 General Atomics Methods and compositions for assaying homocysteine
US7485666B2 (en) 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
WO2015006934A1 (en) * 2013-07-17 2015-01-22 国家纳米科学中心 Small-molecule drug screening chip, construction method therefor and application thereof
CN104111337B (en) * 2014-05-07 2016-01-06 山东博科生物产业有限公司 The homocysteine detection kit of strong interference immunity
CN106434786B (en) * 2015-08-21 2020-08-25 光明乳业股份有限公司 Method for preparing exopolysaccharide by fermenting lactobacillus casei
AU2016354030B2 (en) 2015-11-09 2022-09-15 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
US11324811B2 (en) 2017-04-17 2022-05-10 The Regents Of The University Of Colorado, A Body Corporate Optimization of enzyme replacement therapy for treatment of homocystinuria
CN108486007B (en) * 2018-03-22 2020-10-13 嘉兴益诺康生物科技有限公司 Lactobacillus casei strain for reducing blood uric acid, probiotic composition and application thereof
CN110097928B (en) * 2019-04-17 2022-03-11 广东省科学院微生物研究所(广东省微生物分析检测中心) Prediction method and prediction model for predicting tissue trace element content based on intestinal flora
CN114460159B (en) * 2022-02-17 2023-11-03 河南中医药大学 ALP activity detection kit based on photo-ATRP signal amplification strategy and application method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2054674C1 (en) * 1987-04-10 1996-02-20 Дзе Флиндерс Юниверсити оф Саут Аустрэлиа Method of potassium ion concentration assay in biological material
GB9022304D0 (en) * 1990-10-15 1990-11-28 Ares Serono Res & Dev Ltd Assay technique
CZ287334B6 (en) * 1992-01-22 2000-10-11 Axis Biochemicals As Homocysteine analysis method
US5679548A (en) * 1993-02-02 1997-10-21 The Scripps Research Institute Methods for producing polypeptide metal binding sites and compositions thereof
CA2269659A1 (en) * 1996-11-04 1998-05-14 Merck Frosst Canada & Co. Hydrolase binding assay
DE19757571A1 (en) * 1997-12-23 1999-06-24 Hartmut Prof Dr Oswald Detection of adenosine in biological fluids, by forming enzyme complex

Also Published As

Publication number Publication date
GB0200425D0 (en) 2002-02-27
WO2001002600A3 (en) 2002-01-10
GB2368641A (en) 2002-05-08
GB2368641B (en) 2004-10-06
CA2377665A1 (en) 2001-01-11
WO2001002600A9 (en) 2002-07-25
WO2001002600A2 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
AU2002224831A1 (en) Kit and method for determining multiple analytes
AU2777599A (en) Automated assaying device
AU4568799A (en) Biosensor
AU9586798A (en) Analyte assaying device
AU5526500A (en) Sensor platform and method for analysing multiple analytes
AU6976298A (en) Improved urine specimen container and method for using same
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU4322999A (en) Methods and compositions for diagnosing tauopathies
AU5142699A (en) Methods and compositions for increasing insulin sensitivity
AU2001271720A1 (en) Methods and compositions for determining gene function
AU2030000A (en) Methods and compositions for identifying receptor effectors
AU5781800A (en) Methods and compositions for assaying analytes
AU2288200A (en) Method and device for determining an analyte
AU3268201A (en) Method for evaluating and selecting middleware
AU2308900A (en) Analysis method
AU2001249444A1 (en) Methods and compositions for the simultaneous detection of multiple analytes
AU5394200A (en) Method and kit for ligand assay
EP1031954A3 (en) Measuring arrangement and method
AU2706799A (en) Dynamometer
AU5763100A (en) Non-destructive cell-based assay
WO2001029756A8 (en) Autogrid analysis
AU3266299A (en) Sample diluter
AU5436499A (en) Assay method for cardiovascular disease
AU2188401A (en) Assay method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase